Use of antibodies against Epstein–Barr virus nuclear antigen 1 for detection of cellular proteins with monomethylated arginine residues that are potentially involved in viral transformation
Archives of Virology · 2024
DOI: 10.1007/s00705-024-06172-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Virology, 2024. Verfasst von Christian Graesser und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Virology, Saarland University Medical School, Kirrbergerstraße, Haus 47, D-66421, Homburg/Saar, Germany. Hauptthemen laut MEDLINE: Epstein-Barr Virus Nuclear Antigens, Herpesvirus 4, Human, Arginine. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universität des Saarlandes.
Abstract (Originalsprache)
Epstein–Barr virus nuclear antigen 1 (EBNA1) contains two arginine-glycine (RG) repeats that contain symmetric/asymmetric dimethylarginine (SDMA/ADMA) and monomethylarginine (MMA) residues. We generated mouse monoclonal antibodies directed against a monomethylated GRGRGG-containing repeat located between amino acids 328 and 377 of EBNA1. In addition to detecting MMA-modified EBNA1, we also had the goal of identifying cellular proteins that bind to MMA-modified EBNA1 in EBV-positive Raji cells. Furthermore, we hypothesized that antibodies against MMA-modified EBNA1 might also recognize cell factors that use an MMA-modified surface structure similar to that of EBNA1 to bind to their common targets. Using a combination of immunoprecipitation and mass spectrometry, we identified a number of such cellular proteins, including SNRPD1-3, ALY/REF, RPS15, DIDO1, LSM12, LSM14A, DAP3, and CPSF1. An NACA complex protein that was shown previously to bind to the glycine-alanine repeat of EBNA1 was also identified. The proteins identified in this study are involved in splicing, tumorigenesis, transcriptional activation, DNA stability, and RNA processing or export.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Virology, Saarland University Medical School, Kirrbergerstraße, Haus 47, D-66421, Homburg/Saar, Germany.
- Department of Biology II, Ludwigs-Maximilians-Unversität (LMU) Munich, Butenandtstraße 1, 81377, Munich, Germany.
- Institute of Human Genetics, Saarland University (USAAR), Kirrbergerstraße, Haus 60, 66421, Homburg/Saar, Germany.
- Laboratory for Functional Genome Analysis (LAFUGA), Gene Center, LMU Munich, Feodor-Lynen-Straße 25, 81377, Munich, Germany.
- Center of Human and Molecular Biology (ZHMB), Institute of Human Genetics, Saarland University (USAAR), Kirrbergerstraße, Haus 60, Building 60, D-66421, Homburg/Saar, Germany. martin.hart@uks.eu.
Förderung
- Universität des Saarlandes
Zitieren
APA
Graesser, C., Nord, R., Flaswinkel, H., Kremmer, E., Meese, E., Caban, K. M., Fröhlich, T., Grässer, F. A., & Hart, M. (2024). Use of antibodies against Epstein–Barr virus nuclear antigen 1 for detection of cellular proteins with monomethylated arginine residues that are potentially involved in viral transformation. Archives of Virology. https://doi.org/10.1007/s00705-024-06172-7
Vancouver
Graesser C, Nord R, Flaswinkel H, Kremmer E, Meese E, Caban KM, et al. Use of antibodies against Epstein–Barr virus nuclear antigen 1 for detection of cellular proteins with monomethylated arginine residues that are potentially involved in viral transformation. Archives of Virology. 2024. doi:10.1007/s00705-024-06172-7
BibTeX
@article{Graesser2024,
author = {Graesser, Christian and Nord, Ruth and Flaswinkel, Heinrich and Kremmer, Elisabeth and Meese, Eckart and Caban, Karolina Magdalena and Fröhlich, Thomas and Grässer, Friedrich A and Hart, Martin},
title = {Use of antibodies against Epstein–Barr virus nuclear antigen 1 for detection of cellular proteins with monomethylated arginine residues that are potentially involved in viral transformation},
journal = {Archives of Virology},
year = {2024},
doi = {10.1007/s00705-024-06172-7}
}
EUVIMED